Controversy surrounds the use of antibiotics in the treatment of enterohemorrhagic Escherichia coli (EHEC) infections due to concerns about triggering hemolytic-uremic syndrome (HUS). The most common EHEC serotype causing human diseases worldwide is O157:H7.
Antibiotic therapy is generally NOT beneficial or recommended in patients with EHEC infection (particularly in children <10 years).
WHY? Several studies have shown increased induction of Shiga toxin with antibiotic therapy (i.e fluoroquinolones, trimethoprim-sulfamethoxazole, ampicillin). Shiga toxin is the major virulence factor of EHEC involved in the pathogenesis of HUS.
REFERENCES
Though often used synonymously; Trapped Lung and Lung Entrapment technically describe separate entities along the…
It is not clearly understood why patients with pulmonary hypertension (PH) develop pericardial effusions. However,…
The two drugs are not interchangeable nor dose equivalents. Mycophenolate mofetil (Cellcept) is a semi…
Serum Creatinine can be a deceptive surrogate during an acute kidney injury. It may lag…
Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic diseases (i.e SLE, Juvenile idiopathic…
After creation of a percutaneous tracheotomy site for prolonged ventilation, one of the immediate complications…
This website uses cookies.